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Burton JL, Madsen SA, Yao J, Sipkovsky SS, Coussens PM: An immunogenomics
approach to understanding periparturient immunosuppression and mastitis sus-
ceptibility in dairy cows. Acta vet. scand. 2003. Suppl. 98, 71-88. – Studies compar-
ing in vivo and in vitro functional capacities of leukocytes from non-parturient and peri-
parturient dairy cows have provided substantial evidence that systemic and local
mammary immune defenses are deficient around parturition. This evidence has lead to
the reasonable hypothesis that immune deficiency underlies the heightened mastitis sus-
ceptibility of periparturient cows. Nutrition and vaccine studies substantiate this hy-
pothesis, showing that dietary antioxidant supplementation and rigorous immunization
regimes can bolster innate and humoral immunity to the point that mastitis severity and
time for return to normal milk production are reduced. However, completely effective
resolution of this significant production disease has not been achieved because so little
is understood about its complex etiology. In particular, we possess almost no knowledge
of how or why immune cells responding to parturient physiology end up with deficient
functional capacities. Fluctuations in reproductive steroid hormones and chronic shifts
in neuroendocrine hormones with roles in nutrient partitioning and appetite control may
affect the expression of critical leukocyte genes in periparturient dairy cows. A thorough
understanding of leukocyte biology during periparturition would seem a critical goal for
future development of effective mastitis prevention strategies. Recently, our group has
begun to use cDNA microarray technology to explore bovine leukocyte RNA for global
gene expression changes occurring around parturition. We are working within the con-
text of a hypothesis that the physiology of parturition negatively affects expression of
critical genes in blood leukocytes. In the current study we initiated hypothesis testing
using leukocyte RNA from a high producing Holstein cow collected at 14 days prepar-
tum and 6 hours postpartum to interrogate a cDNA microarray spotted with >700
cDNAs representing unique bovine leukocyte genes. This analysis revealed 18 genes
with ≥1.2-fold higher expression 14 days prepartum than 6 hours postpartum. BLASTN
analysis of these genes revealed only one that can be considered a classical immune re-
sponse gene. All other repressed genes were either unknown or putatively identified as
encoding key proteins involved in normal growth and metabolism of cells. Given the
critical roles of these repressed genes in normal cell functions, we may have identified
good candidates to pursue with respect to periparturient immunosuppression and mas-
titis susceptibility. 
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genomics; gene expression; dairy cattle.
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Introduction
Despite rigorous management practices aimed
at environmental cleanliness, good nutrition,
and vaccination, mastitis remains a problem in
high producing dairy cows during periparturi-
tion (Eberhart 1984, 1986, Erskine et al. 1988,
Gonzalez et al. 1988, Hogan et al. 1989, Gon-
zalez et al. 1990, Hoblet 1991, Erskine &
Bartlett 1995, National Mastitis Council 1996).
Periparturient mastitis susceptibility undoubt-
edly is related to the generalized immune sup-
pression that occurs from approximately 1
week prepartum to 1 week postpartum (Hill et
al. 1979, Guidry et al. 1976, Hill 1981, Oliver
& Sordillo 1988, Nagahata et al. 1988, Kehrli
et al. 1989a,b, Cai et al. 1994, Detilleux et al.
1994, 1995a,b, Sordillo et al. 1997, Lee and
Kehrli 1998, Mallard et al. 1998, Van Kampen
et al. 1999, Waller 2000). This scenario can be
improved somewhat by dietary supplementa-
tion with certain vitamins and minerals (re-
viewed by Burton et al. 2000) and by dry period
vaccination programs (Gonzalez et al. 1989,
Hogan et al. 1989, Gonzalez et al. 1990, Cullor
1991, Hogan et al. 1992a,b, Tyler et al. 1992).
However, our fight against periparturient masti-
tis will continue to be incomplete until we find
out why cows become immunosuppressed
around parturition and discover what genes are
responsible for this condition. Once known, ex-
pression of these genes could be manipulated
through effective dietary supplements, novel
pharmacological therapies, and genetic selec-
tion strategies to improve mastitis resistance.
Of these approaches, genetic selection against
periparturient mastitis susceptibility may be the
best long-term strategy because it offers the
possibility for permanent resolution of this sig-
nificant disease problem.
Dairy cattle breeders have concentrated on the
improvement of milk output and quality at the
expense of disease resistance (Freeman & Lind-
berg 1993, Funk 1993, Schutz 1994). That the
ability of animals to resist infections are, in
part, genetically controlled is not a new concept
(Legates & Grinnells 1952). Therefore, selec-
tion against mastitis susceptibility is possible
(Lindé 1982, Jensen et al. 1981, Lindé 1982,
Skjervold 1982, McDnaiel 1984, Solbu 1984,
Uribe et al. 1995). Research in this area has a
long history and has been focused primarily on
determining appropriate traits or markers for
genetic selection (e.g., Lie 1977; Lindström &
Syväjärvi 1978, Lie 1979, Lie & Solbu 1981,
Almlid 1981, Lie et al. 1982, Mazengera et al.
1985, Lie et al. 1986, Lewin 1989, Strandberg
& Shook 1989, Vage et al. 1992, Mejdell et al,
1994, Shook 1993, Shook & Schutz 1994, De-
tilleux et al. 1994, 1995a, Vecht et al. 1985,
Dietz et al. 1997, Kelm et al. 1997, Sharif et al.
1998, 1999, Wagter et al. 2000). In these stud-
ies, immune response traits measured in vivo
and in vitro usually posses higher heritabilities
than mastitis itself, indicating that an animal’s
level of immunocompetence around parturition
may hold the key to identifying genes that make
breeding stock genetically superior for mastitis
resistance (Detilleux et al. 1994, 1995a,b).
However, researchers still have no knowledge
of the genes that regulate normal immune resis-
tance against mastitis-causing pathogens, let
alone the genes involved in the complex etiol-
ogy of periparturient immunosuppression that
leads to mastitis susceptibility.
To gain clearer understanding of the complexi-
ties of periparturient immunosuppression and
possible genetic links between these and masti-
tis susceptibility will require that we dramati-
cally change our experimental approaches to
these problems (Madsen et al. 2000, Burton
2001, Yao et al. 2001). Our research group has
embraced such change and is now using a holis-
tic functional genomics approach to study en-
dogenous responses of bovine leukocytes to the
entire periparturient physiology. In this way, we
are allowing leukocytes to tell us their own
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story about what genes are involved in normal
immunocompetence and in the suppression of
immunocompetence that occurs around parturi-
tion (Burton 2001). This paper focuses on our
first cDNA microarray analysis of global gene
expression changes that occur in bovine blood
leukocytes around parturition.
Materials and methods
Construction of the bovine total leukocyte
cDNA library
A detailed description of the development of
our bovine total leukocyte (BOTL) cDNA li-
brary is given in a companion paper (Yao et al.
2001, this issue). Briefly, the library was gener-
ated from pooled poly (A)+ RNA isolated from
total peripheral blood leukocytes of 4 healthy,
mid-lactation Holstein cows. The library was
size-selected to eliminate small cDNAs (i.e.,
<500 bp) and normalized to reduce redundancy
of highly abundant transcripts (e.g, GAPDH).
Over 1,000 colonies of the library were ran-
domly picked (GeneTAC G3 picking robot; Ge-
nomic Solutions, Inc.) and subjected to high-
throughput DNA sequencing (ABI BigDye
terminator sequencing kits and an ABI 3700
automatic DNA analyzer; both from Perkin-
Elmer/ABI, Palo Alto, CA). Resulting clone se-
quences were trimmed of vector DNA and final
insert sequences loaded into our database
(http://gowhite.ans.msu.edu) for BLAST (basic
local alignment search tool) analysis against the
GenBank and TIGR (The Institute for Genome
Research) databases.
Production of cDNA microarrays
The cDNA microarray used for this study con-
tained triplicate spots for 720 unique cDNAs
from our BOTL library and is described in de-
tail in our companion paper (Yao et al. 2001,
this issue). Briefly, clone inserts from the BOTL
library were amplified directly from bacteria
using PCR, purified, and suspended in 17 µl of
50% DMSO for spotting on the microarray
(GeneTAC G3 arraying robot; Genomic Solu-
tions, Inc., Ann Arbor, MI). The microarray
was spotted with 48 patches (Fig. 1a) each de-
signed in an 8 × 8 pattern (i.e., 64 spots per
patch) including:
-3 GAPDH spots (a normalizing control for po-
tential RNA loading differences and dye ef-
fects; yellow arrow heads in Fig. 1b);
-2 synthetic lambda Q gene spots (positive con-
trol; white arrow heads in Fig. 1b), one in
the upper right corner of each patch sur-
rounded by 3 blank spots (as landmarks dur-
ing array image analysis; white box in Fig.
1b);
-16 blank spots (to control for background ef-
fects on a patch specific basis; black regions
in Fig. 1b); and
-1 spot containing only DMSO (negative con-
trol; white circles in Fig. 1b); and
-14 BOTL cDNAs spotted in triplicate (e.g., red
and green arrow heads in Fig. 1b).
Experimental Design
Blood from one periparturient primiparous
Holstein cow was used for the current microar-
ray experiment. This cow was housed and cared
for at the Michigan State University’s Dairy
Teaching and Research Facility, and was
healthy by all standard measures. Based upon
our previous results showing differential ex-
pression of numerous genes in blood neu-
trophils collected prepartum and immediately
postpartum (Madsen et al. 2000, Weber et al.
2001), we collected blood from our test cow at
day 14 prepartum (d-14) and 6 hours postpar-
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BLAST (basic local alignment search tool); BOTL
(bovine total leukocyte); TIGR (The Institute for
Genome Research).
tum (h +6) (Fig. 2). Blood was collected from
the coccygeal (tail) vein into a series of four 6-
ml evacuated collection tubes (per sample
time), each containing 1.0 ml of acid citrate
dextrose (ACD) anticoagulant (Fisher Scien-
tific, Pittsburgh, PA). We used 20-gauge, 2.5-
cm multiple sample needles (Fisher Scientific)
to obtain the blood, which was immediately
placed on ice for transport to our laboratory (~7
minute drive).
Preparation of leukocytes and RNA isolation
Once in the laboratory, chilled blood samples
were prepared immediately for RNA isolations.
All glassware was DPEC-treated and solutions
autoclaved and chilled to 4°C for 24 hours prior
to use for leukocyte preparations and RNA iso-
lations. Briefly, each 6 ml tube of chilled whole
blood was decanted to a sterile 50 ml conical
tube preloaded with 30 ml of cold hypotonic
lysing solution (10.56 mM Na2HPO4, 2.67 mM
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Figure 1. The microarray contained 720 unique bovine cDNAs arrayed in 48 patches across a glass microscope
slide (a), each gene was spotted in triplicate within a single patch (b). Each patch was designed as an 8 x 8 array
of spotted cDNAs originating from our bovine total leukocyte (BOTL) library (see Yao et al., 2001; this issue).
Multiple controls were included in each patch as shown in panel (b): 3 GAPDH spots (yellow arrow heads), 2
synthetic lambda Q gene spots (white arrow heads) with one in the upper right corner of each patch surrounded
by 3 blank spots (white box), 16 blank spots (black areas), and 1 spot containing only DMSO (white circle). In




NaH2PO4, pH 7.3), and the tubes gently swirled
for 90 seconds to lyse all erythrocytes. Iso-
tonicity was restored in each tube after exactly
90 seconds by adding 15 ml of ice cold hyper-
tonic restoring solution (10.56 mM Na2HPO4,
2.67 mM NaH2PO4, 0.43 M NaCl, pH 7.3).
Leukocytes remaining in each tube were pel-
leted by centrifugation (1000 × g for 5 min at
4°C), supernatants aspirated and discarded,
cells washed (1000 × g for 5 min at 4°C) in
20 ml of ice cold PBS, and the pellets dissolved
in 8 ml of cold TRIzol reagent (Life Technolo-
gies; Gaithersberg, MD) for 10 min at room
temperature. Time that elapsed from blood
sampling to cell lysis in TRIzol Reagent was
less than 1.5 hours. Individual samples were
pooled into one tube by collection time and
stored in the TRIzol at –80°C until RNA isola-
tions were performed. RNA isolations were
done according to the TRIzol manufacturer’s
instructions within a week of the h +6 sample
collection. RNA concentrations and purities
were determined on both pooled samples using
spectrophotometry (260 and 280 nm readings;
DU-650 spectrophotometer Beckman, Schaum-
burg, IL) and agarose gel electrophoresis (28
and 18 S rRNA band visualization following
ethidium bromide staining). By these assess-
ments, we obtained 30-40 µg of good quality
leukocyte total RNA from each 24 ml of blood
collected.
RNA labeling and hybridization to microarray
Leukocyte total RNAs (5-20 µg) from blood
samples collected on d -14 and h +6 were used
as templates in 2 separate reverse transcription
reactions (described in detail in our companion
paper, Yao et al. 2001, this issue). Briefly, syn-
thetic lambda Q gene RNA was spiked into
each reaction (as a control for cDNA synthesis
and as a positive hybridization control; Fig. 1b)
and oligo (dT)15 used as the primer for reverse
transcription. First-strand cDNA from the d –14
and h +6 samples were differentially labeled
with Cy5 and Cy3, respectively, using a com-
mercial kit (Clontech, Inc., Palo Alto, CA), and
the labeled cDNAs mixed and hybridized to the
microarray (Fig. 2). Hybridization was per-
formed for ~18 hours at 50°C in a sealed, hu-
midified chamber (TeleChem International,
Inc.; Sunnyvale, CA). Following hybridization,
the microarray was washed 3 times, rinsed in
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Figure 2. Leukocyte RNA from freshly sampled
d-14 and h +6 blood was converted to cDNA by re-
verse transcription and the cDNAs differentially la-
beled with Cy5 and Cy3, respectively. The labeled
cDNAs were mixed and hybridized to the microarray.
After array scanning the Cy5 profile was integrated
with the Cy3 profile to give a final emission profile of
red, green and yellow spots (see Figure 1). Red spots
represent leukocyte genes preferentially expressed
on d-14, green spots represent leukocyte genes pref-
erentially expressed at h +6, and yellow spots repre-
sent leukocyte genes expressed equally on d-14 and h
+6.
ddH2O, and dried by centrifugation in a cush-
ioned 50 ml conical centrifuge tube. The final
microarray was immediately scanned (Gene-
TAC LS IV array scanner; Genomic Solutions),
the image processed (GeneTAC LS software;
Genomic Solutions, Inc.), and spots located
(Fig. 1) and integrated with the spotting file of
the robot. Finally, reports were created of total
spot information and spot intensity ratio for
subsequent data analyses.
Data Analyses
All spot data from this experiment were im-
ported into a Microsoft Excel worksheet for
analysis. Data were sorted by spot type and dye
color so Cy3 and Cy5 profiles for the GAPDH
dye/RNA loading and lambda Q gene controls
could be assessed. First, GAPDH Cy3 intensity
was regressed on GAPDH Cy5 intensity to de-
termine if significant dye/RNA loading effects
were present. We proceeded with analysis of the
test spots without adjustments for GAPDH or
lambda Q because individual BOTL cDNA
were spotted on the microarray (in triplicate)
within a single patch (Fig. 1b). Therefore, patch
effects did not influence our ability to test our
hypothesis that parturition alters leukocyte
gene expressions.
For analysis of our test samples, spot data were
resorted by clone number and dye to isolate the
Cy3 and Cy5 labeled BOTL cDNAs. These
were copied into a separate Excel worksheet,
triplicate spot data plotted in a scatter graph,
and Cy3 intensities regressed against Cy5 in-
tensities to obtain a regression line. The sample
mean Cy5 and Cy3 intensities for each of the
triplicate spots were estimated and Student’s 2-
tailed t-test was used to determine if expres-
sions were significantly different on d -14 ver-
sus h +6. We also calculated Cy5:Cy3 ratios of
the mean spot intensities to get an indication of
the fold-changes in expressions of the BOTL
genes from d -14 to h +6. These Cy5 and Cy3
sample means and Cy5:Cy3 ratios are the data
sets presented in the Results section.
Northern blot validation of differential gene 
expressions
Clones containing inserts for 3 BOTL cDNAs
identified on our microarray as true red in color
(i.e., repressed in blood leukocytes at h +6 rela-
tive to d-14) were selected as probes for North-
ern blot validation of differential gene expres-
sion. Blots were also probed with the GAPDH
cDNA for normalizing purposes. Prior to ra-
dioactive labeling, the inserts of these 4 clones
were PCR-amplified and visualized as single
bright bands on a 1.0% agarose gel stained with
ethidium bromide (not shown). Northern blot
analysis was performed using total RNA iso-
lated on d –14 and h +6 from leukocytes of one
healthy periparturient Holstein cow (a different
cow than for the microarray experiment) and a
mix of leukocyte RNA from 4 healthy control
cows in mid-gestation. Aliquots of 10 µg of
RNA from each sample were electrophoresed
in a 15 × 10 cm 1.2% denaturing agarose gel
(Sub-Cell GT System; BioRad, Hercules, CA).
Separated RNA was transferred from the gel to
a nylon membrane (Hybond, Amersham Phar-
macia Biotech, Buckinghamshire, UK) and
baked for 2 hours at 80°C. The blot was pre-hy-
bridized for 2 hours at 68°C in 10 ml of Perfec-
tHyb Plus hybridization solution (Sigma; St.
Louis, MO) containing 400 µg/ml of herring
sperm DNA. Hybridization was carried out for
16 h at 68°C in the same solution using the
cDNA probes labeled with 32P (NEN Life Sci-
ence Products, Inc.; Boston, MA) by the ran-
dom prime method (Feinberg & Vogelstein
1983). After hybridizations, the membranes
were washed once at room temperature with 2x
SSC, 0.1% SDS for 5 min and 2 times with 0.5x
SSC, 0.1% SDS at 68°C for 20 min prior to ex-
posure to BioMax MS film (Fisher Scientific,
Pittsburgh, PA) for 19 hours at –80°C with an
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intensifying screen (Fisher Scientific, Pitts-
burgh, PA). Expressions of the 3 test transcripts
and the GAPDH transcript were estimated from
each band using a scanning densitometer (GS-
710 Calibrated Imaging Densitometer and
Multi-Analyst Software; BioRad, Hercules,
CA; data not shown) and expression data for the
test transcripts recorded as a ratio to GAPDH
expression.
Results
As shown in the scatter plot in Fig. 3a, the Cy3
and Cy5 spots for GAPDH lay in a relatively
tight cluster and very close to the regression
line, which had a slope of ~1.0. Therefore, ex-
cept for 5 or 6 outliers (expected for this scale
of gene expression analysis), we observed no
particular trends in dye or RNA loading effects
in this experiment (i.e., the Cy3 intensity was
equal to the Cy5 intensity for GAPDH). One
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Figure 3. Regression analyses of the GAPDH control spots (a) and the lambda Q gene control spots (b) on the
cDNA microarray shown in Fig. 1a. In these analyses, Cy3 spot intensities (volumes) were regressed on Cy5 spot
intensities to determine if the GAPDH and lambda Q spots were yellow (i.e., lying close to the regression line
and indicating no dye/RNA loading effects) and well clustered (i.e., showing no patch variation).
point of note, however, was that the GAPDH
spots had a tendency to form a narrow tail into
the low intensity region of the plot (Fig. 3a). We
took this to mean that not all of the GAPDH
spots yielded the same yellow intensity due to
patch-specific effects. Indeed, a similar analysis
of the lambda Q gene spots (2 per patch for a to-
tal of 96 spots) showed evidence of patch ef-
fects because there was a stretched line of Cy3-
Cy5 data points instead of a defined cluster of
points (Fig. 3b). However, the slope of this re-
gression line was also close to 1.0 with tight
hovering of the lambda Q Cy3 and Cy5 spots to
the regression line. As for the GAPDH analysis,
this indicated no dye or RNA loading effects.
As shown in Fig. 4, the regression of Cy3 and
Cy5 had a slope of 0.9997 with most data points
clustering tightly to the line (R2 = 0.938). This
indicated that most of the test spots had various
intensities of yellow fluorescence, the genes
represented by the cDNAs on those spots being
expressed equally at d -14 and h +6. No leuko-
cyte genes appeared to be activated at h +6 be-
cause no spots were obviously more green
(Cy3) than red (Cy5) (Fig. 4). However, a small
cluster of genes did fall into the Cy5 region of
the plot (Fig. 4) and appeared obviously red on
the processed microarray file (Fig. 1), showing
that these genes were repressed at h +6 relative
to d -14.
Data obviously falling away from the regres-
sion line into the Cy5 region of the BOTL scat-
ter plot (Fig. 4) represented triplicate spots for
18 BOTL cDNAs. These spots lay clearly in the
Cy5 region of the scatter plot indicating that the
18 genes represented by them were repressed 6
hours following parturition (h +6) compared to
14 days prepartum (d –14). Therefore, we have
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Figure 4. Regression analysis of the BOTL test spots on the cDNA microarray shown in Fig. 1. In this analyses,
Cy3 spot intensities (volumes) were regressed on Cy5 spot intensities to determine if the leukocytes collected 6
hours postpartum (h +6) had different gene expressions than leukocytes collected 14 days prepartum (d –14).
This analysis showed that most leukocyte genes represented on our microarray were equally expressed on d –14
and h +6 because the majority of the spots on the scatter plot clung tightly to the regression line, which had a
slope very close to 1.0. However, this analysis revealed 54 overlapping spots in the Cy5 area of the plot, which
represented triplicate spots for 18 unique BOTL cDNAs that were repressed 6 hours after parturition.
14 days pre- versus 6 hours post parturition
identified 18 leukocyte genes that are repressed
during parturition.
The wide distribution of the clustered Cy5
spots in the scatter plot in Fig. 4 indicated wide
variation in red dye intensities amongst these
18 BOTL cDNAs. These could be seen on the
actual microarray as spots that ranged in color
from true red to reddish-brown (Fig. 1). Differ-
ences in Cy5 intensity of these spots could
mean that these 18 genes have different expres-
sion levels in bovine blood leukocytes. How-
ever, given the patch-to-patch variation in the
Cy3-Cy5 (yellow) spot intensities of the
lambda Q gene (Figs. 1a and 3b), differences in
the Cy5 intensities of this cluster of red BOTL
spots may simply reflect the patch variation on
our microarray. Establishing the relative contri-
butions of gene expression versus patch varia-
tion in this study would require additional
Northern blot and microarray analyses of these
18 BOTL cDNAs. However, source of variation
in Cy5 intensity from cDNA to cDNA was not
important in the current study because our goal
was to test differences in expression between
the d –14 and h +6 samples within individual
cDNAs. This goal was reflected in the fact that
we spotted individual cDNAs only within a
patch and not across patches on the microarray
(Fig. 1; refer to Materials and methods section).
Nonetheless, for simplification of data presen-
tation we have plotted the sample means
(± SEM) for expression differences in our 18
BOTL cDNAs by relative Cy5 intensity level
(i.e., expression on d –14). Six of these cDNAs
fell in the low intensity region (Cy5 intensity
range ~50,000 to 400,000; Fig. 5), 8 in the
medium intensity region (Cy5 intensity range
~100,000 to 700,00; Fig. 6), and 4 in the high
intensity region (Cy5 intensity range ~200,000
to 12,000,000; Fig. 7). 
Sample means in Fig. 5 show that leukocyte
genes represented by our BOTL clones 8_F09,
6XG09R, 4XD09R, and 8_B07 were signifi-
cantly (P ≤0.04) repressed on h +6 compared to
d –14 relative to parturition. These genes were
~1.5-fold to 4-fold higher in expression in the
prepartum sample than the postpartum sample
(Fig. 8). Leukocyte genes represented by BOTL
clones 9_F09 (P = 0.06) and 5XC11R (P =
0.13) tended to be lower at h +6 compared to d
–14 (Fig. 5). These genes both had ~1.5-fold
higher expression prepartum than postpartum
(Fig. 8). BLASTN results in Table 1 showed
that the BOTL cDNA sequences for the 6 re-
pressed genes in Fig. 5 were either unknown
(9_G07, 4XD09R) or had high homology with
molecules involved in DNA binding and tran-
scription (6XG09R, 8-B07) and signal trans-
duction (8_F09). Sample means in Fig. 6 show
that leukocyte genes represented by our BOTL
clones 12_B09, 12_B06, 8_B05, 13_B06,
6XC10R, 10-A07, and 3XA10R were also sig-
nificantly (P ≤0.04) repressed on h +6 com-
pared to d –14. These genes were expressed
~1.2-fold to 3.5-fold higher in the prepartum
sample than the postpartum sample (Fig. 8).
The leukocyte gene represented by BOTL clone
4XD08R tended (P = 0.06) to be lower at h +6
compared to d –14 (Fig. 6). This gene had ~2.3-
fold higher expression prepartum than postpar-
tum (Fig. 8). BLASTN results in Table 1
showed that the BOTL cDNA sequences for the
8 repressed genes in Fig. 6 were either unknown
(8_B05, 10_A07) or had high homology with a
variety of molecules involved in hormone bind-
ing (12_B09), cell growth (12_B06), leukocyte
extravasation (6XC10R), and cell signaling
(4XD08R, 3XA10R). Finally, sample means in
Fig. 7 show that leukocyte gene expression rep-
resented by our BOTL clones 6XH09R,
3XD01R, 8_F08, and 2XH12R were highly sig-
nificantly (P ≤0.004) repressed at h +6 com-
pared to d –14. These genes were ~1.7-fold to
4-fold higher in expression in the prepartum
sample than the postpartum sample (Fig. 8).
BLASTN results in Table 1 showed that the
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Figure 5. Sample mean fluorescence intensities ( ± SEM) of triplicate spots for 6 leukocyte clones identified
by cDNA microarray analysis to be repressed at 6 hours postpartum (h +6; striped bars) compared to 14 days
prepartum (d –14; open bars). Data are for BOTL clones showing lowest Cy5 (red; d -14) intensities on the mi-
croarray in Fig. 1 and falling in the cluster of Cy5 spots in Fig. 4. High Cy5 intensity relative to Cy3 intensity in
each cluster of 2 bars shows that genes represented by these 6 BOTL clones were significantly repressed fol-
lowing parturition (numbers above the open bar in each cluster are the P values from Student’s 2-tailed t-tests).
Figure 6. Sample mean fluorescence intensities ( ± SEM) of triplicate spots for 8 leukocyte clones identified
by cDNA microarray analysis to be repressed at 6 hours postpartum (h +6; striped bars) compared to 14 days
prepartum (d –14; open bars). Data are for BOTL clones showing medium Cy5 (red; d -14) intensities on the mi-
croarray in Fig. 1 and falling in the cluster of Cy5 spots in Fig. 4. High Cy5 intensity relative to Cy3 intensity in
each cluster of 2 bars shows that genes represented by these 6 BOTL clones were significantly repressed fol-
lowing parturition (numbers above the open bar in each cluster are the P values from Student’s 2-tailed t-tests).
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Figure 7. Sample mean fluorescence intensities ( ± SEM) of triplicate spots for 4 leukocyte clones identified
by cDNA microarray analysis to be repressed at 6 hours postpartum (h +6; striped bars) compared to 14 days
prepartum (d –14; open bars). Data are for BOTL clones showing high Cy5 (red; d -14) intensities on the mi-
croarray in Fig. 1 and falling in the cluster of Cy5 spots in Fig. 4. High Cy5 intensity relative to Cy3 intensity in
each cluster of 2 bars shows that genes represented by these 6 BOTL clones were significantly repressed fol-
lowing parturition (numbers above the open bar in each cluster are the P values from Student’s 2-tailed t-tests).
Figure 8. Mean Cy5:Cy3 intensity ratios for 18 leukocyte genes identified by cDNA microarray analysis to be
repressed at 6 hours postpartum compared to 14 days prepartum. Data are for 18 BOTL clones showing as red
spots on the microarray in Fig. 1 and falling in the cluster of Cy5 spots in Fig. 4. Data in this figure showed that
the 18 leukocyte genes represented by these BOTL clones had between 1.2-fold and 4-fold higher expression
levels 14 days before parturition than 6 hours after parturition.
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Table 1. Results of BLASTN analysis of 18 BOTL sequences shown by cDNA microarray analysis to be re-
pressed by parturition.
BOTL P-value 1) BLASTN results TIGR Cluster
Clone (d-14 vs h +6) (putative gene identification) E-value 2) (TC#) or
Name GenBank # 3)
Observed by microarray analysis and confirmed by Northern blot hybridization:
6XGO9R 0.02 Kruppel-like factor mRNA 10-37.69 TC71106
8_F09 0.04 Mitogen activated protein kinase 10-57.15 4505262
kinase kinase 10 (MAP3K10) 11425967
mRNA
13_B06 0.04 Unknown - -
Observed by microarray analysis:
9_G07 0.06 Unknown - -
5XC11R 0.13 Bos taurus lysosomal alpha- 10-9 TC74217
mannosidase (ManB) gene
4XD09R 0.002 Unknown - -
8_B07 0.004 Basic leucine zipper transcription 10-116 TC68695
factor-like mRNA
12_B09 0.002 Bovine beta-globulin gene 10-36.3 TC61928
12_B06 0.001 Bovine ornithine decarboxylase 10-19.52 TC69145
(ODC) gene
8_B05 0.02 Unknown - -
6XC10R 0.01 Mus musculus plectin isoform plec 10-28 6578732
0a, 1c (Plec 1) mRNA
4XD08R 0.06 Bos taurus matrix acidic 10-10 TC76407
phosphoprotein mRNA
10_A07 0.007 Unknown - -
3XA10R 0.01 Diphosphoinositol polyphosphate 10-32.15 TC69522
phosphohydrolase
6XH09R 0.003 Long chain fatty acid CoA ligase 4 10-126 TC72044
(acyl CoA synthetase 4)
3XD01R 0.004 Diphosphoinositol polyphosphate 10-31.52 TC69522
phosphohydrolase mRNA
8_F08 0.0002 Unknown - -
2XH12R 0.0006 Bovine mRNA for MHC class II 10-41.69 TC6553
DM ß-chain
1) P-value from the t-tests comparing sample time dye intensities of BOTL spots on the cDNA microarray, 
2) expectation values (E-value) from the BLAST search, and 
3) TIGR cluster number or GenBank number to which the BOTL sequence had homology.
BOTL cDNA sequences for the 4 repressed
genes in Fig. 7 were either unknown (8_F09) or
had high homology with a variety of molecules
involved in fatty acid synthesis (6XH09R), cell
signaling (3XD01R), and antigen presentation
(2XH12R). Northern blot analysis of 6XG09R,
8_F09, and 13_B06 confirmed that these 3
leukocyte genes were significantly repressed
following parturition (Fig. 9). Therefore, re-
sults of our study support our hypothesis by
showing that parturition negatively affects gene
expression profiles of bovine blood leukocytes.
Discussion
We know from extensive literature on the sub-
ject that most functions of bovine leukocytes
are dramatically altered by parturition and that
significant genetic variation exists in these dys-
functional leukocyte traits (see Introduction).
These leukocyte dysfunctions probably under-
lie the heightened mastitis susceptibility of
periparturient cows, but the genes involved in
this complex disease etiology are virtually un-
known. Understanding the molecular bases for
leukocyte dysfunctions around parturition will
open the doors to a plethora of targeted studies
aimed at discovery of multiple management
tools that truly improve mammary immunity
and mastitis resistance in periparturient cows.
Examples include the elucidation of biologi-
cally relevant molecular genetic markers for ge-
netic selection against periparturient mastitis
susceptibility, nutritional and other manage-
ment manipulations to influence leukocyte gene
expression in favor of improved mammary im-
mune defenses, and development of new non-
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Figure 9. Northern blot validation of repressed gene expression in leukocytes from parturient dairy cows.
Three BOTL clones that appeared to have triplicate spots of true red the cDNA microarray (see Fig. 1 b for an
example) were selected for use as cDNA probes on Northern blot analyses of leukocyte RNA from 4 mid-lacta-
tion control cows (RNA was pooled; gray bars) and from one periparturient cow collected 14 days prepartum (d
–14; open bars) and 6 hours postpartum (h +6; striped bars). Band intensities for the 3 test transcripts were nor-
malized against band intensities for GAPDH. These data confirm dye intensity results in Fig. 5 and 6, dye ratio
results in Fig. 8, and visual microarray results in Fig. 1, that genes represented by BOTL clones 6XG09R, 8_F09,
and 13_B06 are repressed right after parturition.
antibiotic pharmaceuticals that protect leuko-
cytes from the suppressing effects of par-
turition. Getting to the bottom of the over-
whelming task of such large-scale gene
identification has been made simple by new
cDNA microarray technology that allows us to
study expression changes in hundreds of cellu-
lar genes at one time (DeBouck & Goodfellow
1999, Khan, et al. 1999, Kurian et al. 1999,
Ramsay 1998, Schena et al. 1998). We took this
holistic approach to begin studying effects of
parturition on leukocyte gene expression pro-
files for a Holstein cow approaching and going
through parturition.
In this study, regression analysis of all test
BOTL spots showed that, as expected, the ma-
jority of leukocyte genes represented on our mi-
croarray were equally expressed 14 days before
and 6 hours after parturition (i.e., were yellow;
Fig. 1 and 4). However, a cluster of spots falling
in the Cy5 region of Fig. 4 showed that 18
leukocyte genes were repressed 6 hours after
parturition, 15 of them significantly so (Figs. 5,
6, and 7) and 12 of them at a level of 2-fold or
higher (Fig. 8). Six of the repressed genes did
not consistently hit DNA sequence targets in
the TIGR or GenBank databases and are thus
currently unknown (Table 1). Of the remaining
12 BOTL genes that did have significant DNA
sequence homology with known genes in the
data bases, only one could be considered a
“classical” immune response gene (2XH12R,
the ß-chain of MHC class II; Table 1). The other
11 leukocyte genes we detected as being re-
pressed by parturition had high DNA sequence
homology with genes known to be important in
normal cell growth, metabolism, and respon-
siveness to the blood environment (Table 1).
Two of these genes are involved in gene tran-
scription itself (6XG09R, 8_B07; Table 1).
Therefore, we conclude from the microarray
data presented in this study that parturition in-
fluences the expression of multiple leukocyte
genes required for normal functioning of these
cells. Repressed expression of these genes
could easily explain the dysfunctional capaci-
ties of leukocytes from periparturient cows re-
ported over the past 3 decades by multiple lab-
oratories (Hill et al. 1979, Guidry et al. 1976,
Hill 1981, Oliver & Sordillo 1988, Nagahata et
al. 1988, Kehrli et al. 1989a,b, Cai et al. 1994,
Detilleux et al. 1994, 1995a,b, Sordillo et al.
1997, Lee & Kehrli 1998, Mallard et al. 1998,
Van Kampen et al. 1999, Waller 2000). How-
ever, we have not yet determined which popula-
tion of leukocytes are affected or what factors
of parturition cause the repression of our 18
leukocyte genes. Preliminary studies from our
group implicate neutrophils as the main leuko-
cyte targets of parturition-induced gene expres-
sion changes (Madsen et al. 2000, Weber et al.
2001). This is important because neutrophils
are the main line of immunological defense
against mastitis-causing bacteria in dairy cows
(Paape et al. 1979). However, additional stud-
ies will be required to determine if the18 re-
pressed genes identified in the current study
were contributed from the neutrophil popula-
tion of circulating leukocytes and if expression
of any of these genes is linked with mastitis sus-
ceptibility around parturition.
Conclusions
The microarray experiment performed in this
study has putatively identified 18 genes nor-
mally expressed in blood leukocytes 14 days
before parturition but dramatically repressed in
leukocytes shortly after parturition. While
some of these leukocyte genes currently have
no known name or function, many of them
showed high DNA sequence homology to genes
required for normal cell functions. Because
many of the genes identified in this study allow
cells to respond to biochemical signals in the
blood environment, it will be interesting to de-
termine in future studies if our observed
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changes in gene expression are related to fluc-
tuating hormone concentrations and nutrient
status of periparturient cows. We hope that the
new knowledge generated about gene expres-
sion changes in leukocytes of parturient dairy
cows will ultimately be useful for the develop-
ment of novel management strategies to combat
immunosuppression and mastitis susceptibility
during this tricky stage in a cow’s lactation cy-
cle. Major future goals of our group will be to
determine which leukocyte genes participate in
the regulation of mammary immunity and study
them as potential candidate markers for genetic
selection to improve mastitis resistance in dis-
ease susceptible periparturient cows. As with so
many colleagues before us, it is our belief that a
genetic approach to improved leukocyte func-
tions will help counteract any negative effects
that selection for high milk yield has had on
mammary immunity.
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